Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial - The Lancet Haematology
Limited systemic sclerosis (CREST syndrome): Video | Osmosis
Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology